Airway inflammation markers in COPD

O. Plekhanova (Dniepropetrovsk, Ukraine)

Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Session: Airway regulation, provocation and monitoring I
Session type: Thematic Poster Session
Number: 2180
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Plekhanova (Dniepropetrovsk, Ukraine). Airway inflammation markers in COPD. Eur Respir J 2007; 30: Suppl. 51, 2180

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006

Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

ADAM33 SNPs are associated with airway hyperresponsiveness and airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 3s
Year: 2005

Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Inflammatory cells and airway remodelling in COPD
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019

Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Airway inflammation and airway dynamics during deep inspiration in asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 831s
Year: 2006

The EvA-Study: Markers of emphysema versus airway disease in COPD
Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC
Year: 2009

Airway remodelling in asthma is related to particular characteristics of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002

Chronic sputum production in COPD is a marker for airway inflammation and colonisation
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004

Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006

Autoimmunity  in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017

Markers of inflammation and airway responses to allergen in asthmatic patients
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Airway inflammatory mediators and airway wall remodelling in asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009

The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020

Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003

Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003